152 related articles for article (PubMed ID: 28232728)
21. [Markov decision analysis on post-remission therapies in patients with acute myeloid leukemia in the first remission].
Kurosawa S
Rinsho Ketsueki; 2012 Feb; 53(2):205-14. PubMed ID: 22450580
[No Abstract] [Full Text] [Related]
22. Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia.
Khawaja MR; Perkins SM; Schwartz JE; Robertson MJ; Kiel PJ; Sayar H; Cox EA; Vance GH; Farag SS; Cripe LD; Nelson RP
Am J Hematol; 2015 Feb; 90(2):97-9. PubMed ID: 25345651
[TBL] [Abstract][Full Text] [Related]
23. ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome.
Damiani D; Tiribelli M; Geromin A; Michelutti A; Cavallin M; Sperotto A; Fanin R
Am J Hematol; 2015 Sep; 90(9):784-9. PubMed ID: 26059733
[TBL] [Abstract][Full Text] [Related]
24. Leukemia-associated aberrant immunophenotype in patients with acute myeloid leukemia: changes at refractory disease or first relapse and clinicopathological findings.
Cui W; Zhang D; Cunningham MT; Tilzer L
Int J Lab Hematol; 2014 Dec; 36(6):636-49. PubMed ID: 24602197
[TBL] [Abstract][Full Text] [Related]
25. Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EBMT database.
Sun Y; Beohou E; Labopin M; Volin L; Milpied N; Yakoub-Agha I; Piemontese S; Polge E; Houhou M; Huang XJ; Mohty M; Nagler A; Gorin NC;
Haematologica; 2016 Aug; 101(8):e352-4. PubMed ID: 27081180
[No Abstract] [Full Text] [Related]
26. To transplant or not to transplant for adult acute myeloid leukemia: an ever-evolving decision.
Gerds AT; Appelbaum FR
Clin Adv Hematol Oncol; 2012 Oct; 10(10):655-62. PubMed ID: 23187771
[TBL] [Abstract][Full Text] [Related]
27. Hematopoietic cell transplantation in high-risk childhood acute myelogenous leukemia.
Meshinchi S
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1002-3. PubMed ID: 23791357
[No Abstract] [Full Text] [Related]
28. Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations.
Xu Y; Sun Y; Shen H; Ding L; Yang Z; Qiu H; Sun A; Chen S; Wu D
Am J Hematol; 2015 Nov; 90(11):992-7. PubMed ID: 26223865
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation.
Ishida H; Kato M; Kudo K; Taga T; Tomizawa D; Miyamura T; Goto H; Inagaki J; Koh K; Terui K; Ogawa A; Kawano Y; Inoue M; Sawada A; Kato K; Atsuta Y; Yamashita T; Adachi S
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2141-2147. PubMed ID: 26271192
[TBL] [Abstract][Full Text] [Related]
30. The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study.
Klusmann JH; Reinhardt D; Zimmermann M; Kremens B; Vormoor J; Dworzak M; Creutzig U; Klingebiel T
Haematologica; 2012 Jan; 97(1):21-9. PubMed ID: 21933851
[TBL] [Abstract][Full Text] [Related]
31. Prognosis of acute myeloid leukemia harboring monosomal karyotype in patients treated with or without allogeneic hematopoietic cell transplantation after achieving complete remission.
Yanada M; Kurosawa S; Yamaguchi T; Yamashita T; Moriuchi Y; Ago H; Takeuchi J; Nakamae H; Taguchi J; Sakura T; Takamatsu Y; Waki F; Yokoyama H; Watanabe M; Emi N; Fukuda T
Haematologica; 2012 Jun; 97(6):915-8. PubMed ID: 22180431
[TBL] [Abstract][Full Text] [Related]
32. Discovery of donor genotype associated with long-term survival of patients with hematopoietic stem cell transplantation in refractory acute myeloid leukemia.
Ock CY; Seo H; Kim DY; Min BJ; Park Y; Cheong HS; Kim HL; Song EY; Kim I; Yoon SS; Kim JH; Koh Y
Leuk Lymphoma; 2019 Jul; 60(7):1775-1781. PubMed ID: 30507323
[TBL] [Abstract][Full Text] [Related]
33. Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia.
Malani D; Kumar A; Brück O; Kontro M; Yadav B; Hellesøy M; Kuusanmäki H; Dufva O; Kankainen M; Eldfors S; Potdar S; Saarela J; Turunen L; Parsons A; Västrik I; Kivinen K; Saarela J; Räty R; Lehto M; Wolf M; Gjertsen BT; Mustjoki S; Aittokallio T; Wennerberg K; Heckman CA; Kallioniemi O; Porkka K
Cancer Discov; 2022 Feb; 12(2):388-401. PubMed ID: 34789538
[TBL] [Abstract][Full Text] [Related]
34. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.
Qin YZ; Wang Y; Zhu HH; Gale RP; Zhang MJ; Jiang Q; Jiang H; Xu LP; Chen H; Zhang XH; Liu YR; Lai YY; Jiang B; Liu KY; Huang XJ
Chin J Cancer; 2016 May; 35():46. PubMed ID: 27197573
[TBL] [Abstract][Full Text] [Related]
35. The Changing Face of Oncology Research, Drug Development, and Clinical Practice: Toward Patient-Focused Precision Therapeutics.
Venkatakrishnan K; van der Graaf PH; Holstein SA
Clin Pharmacol Ther; 2020 Sep; 108(3):399-404. PubMed ID: 33439492
[No Abstract] [Full Text] [Related]
36. Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research.
Keating A; DaSilva G; Pérez WS; Gupta V; Cutler CS; Ballen KK; Cairo MS; Camitta BM; Champlin RE; Gajewski JL; Lazarus HM; Lill M; Marks DI; Nabhan C; Schiller GJ; Socie G; Szer J; Tallman MS; Weisdorf DJ
Haematologica; 2013 Feb; 98(2):185-92. PubMed ID: 22983587
[TBL] [Abstract][Full Text] [Related]
37. [Current treatment of acute myeloid leukemia].
Ohtake S
Rinsho Ketsueki; 2012 Oct; 53(10):1560-70. PubMed ID: 23037728
[No Abstract] [Full Text] [Related]
38. Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Salvatore D; Labopin M; Ruggeri A; Battipaglia G; Ghavamzadeh A; Ciceri F; Blaise D; Arcese W; Sociè G; Bourhis JH; Van Lint MT; Bruno B; Huynh A; Santarone S; Deconinck E; Mohty M; Nagler A
Haematologica; 2018 Aug; 103(8):1317-1328. PubMed ID: 29748438
[TBL] [Abstract][Full Text] [Related]
39. Secondary chronic myeloid leukemia following acute myeloid leukemia treated with autologous hematopoietic stem cell transplantation: a case report.
Cheng J; Liao Y; Bin T; OUYang J; Chen S; Chen X; Zou W
Curr Med Res Opin; 2020 Nov; 36(11):1807-1812. PubMed ID: 32936052
[TBL] [Abstract][Full Text] [Related]
40. Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients.
Tien FM; Hou HA; Tsai CH; Tang JL; Chen CY; Kuo YY; Li CC; Lin CT; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Tseng MH; Liu MC; Liu CW; Lin LI; Chou WC; Tien HF
Eur J Haematol; 2018 Jul; 101(1):86-94. PubMed ID: 29624746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
